Add BrightSurf on Google Email

Science News for September 13, 2026


Snail shells are surprise weather time capsules

Researchers used snail shells to recreate prehistoric cyclones in South East Queensland, Australia, by analyzing growth rings and stable isotopes. The study showed that snails responded to extreme rainfall events, not annual wetness, providing a new climate archive for the region.

SourceUniversity of Queensland·JournalThe Holocene·TypeExperimental study·DateSep 13, 2026

Bolstered interfacial field chemistry for deep fast‑charging aqueous zinc metal batteries

Researchers developed a sulfosuccinic acid-enabled interfacial field chemistry strategy to regulate Zn anodes, enabling highly reversible Zn deposition. The optimized electrolyte achieved high Coulombic efficiency and long cycle life, making it suitable for fast-charging and deep Zn utilization.

SourceShanghai Jiao Tong University Journal Center·JournalNano-Micro Letters·TypeNews article·DateSep 13, 2026

Multifunctional conductive and Elastic matrices‑engineered Si nanocomposite anodes for liquid and solid‑state lithium batteries

Researchers developed a novel Si/a-Sn/CoSi2/G/C nanocomposite anode with a hierarchical, multifunctional matrix architecture, achieving simultaneous optimization of electronic conduction, mechanical robustness, and elastic stress recovery without sacrificing practical manufacturability. The anode delivers high reversible capacity, exce...

SourceShanghai Jiao Tong University Journal Center·JournalNano-Micro Letters·TypeNews article·DateSep 13, 2026

University students are less physically active and more sedentary than older adults in their 70s, NUS study finds

University students accumulate less daily physical activity and more sedentary time than older adults, with significant public health implications. The study highlights the need to rethink public health messaging and redesign urban environments to promote incidental movement in younger generations.

Researchers identify ANKRD11 as a brake on T-cell responses to chronic hepatitis B virus and cancer

Researchers identified ANKRD11 as a key regulator that suppresses CD8+ T cell activity during chronic hepatitis B virus infection and cancer. ANKRD11 deficiency reprograms CD8+ T cell differentiation to enhance immunity in chronic infection and cancer, making it a potential therapeutic target.

SourceChinese Academy of Sciences Headquarters·JournalNature Immunology·TypeExperimental study·DateSep 13, 2026

Marine carbohydrate therapeutics: from structural diversity to clinical translation

Marine carbohydrates have shown antiviral, anticoagulant, immunomodulatory, and antitumor activity, with potential applications in drug delivery, wound healing, and tissue engineering. Further research is needed to establish reliable production methods and improve structural and activity-based quality control.

SourceKeAi Communications Co., Ltd.·JournalGlycoscience & Therapy·TypeLiterature review·DateSep 13, 2026

Zipalertinib plus chemotherapy significantly extends progression-free survival in first-line EGFR exon 20 insertion-positive NSCLC

The REZILIENT 3 trial found a six-month improvement in median progression-free survival with the combination of zipalertinib and platinum-pemetrexed chemotherapy. The study showed a 50% reduction in disease progression or death and a substantially higher response rate compared to chemotherapy alone.

Phase 3 DESTINY-Lung04 trial shows first-line trastuzumab deruxtecan significantly improves progression-free survival in HER2-mutant NSCLC

The Phase 3 DESTINY-Lung04 trial showed that trastuzumab deruxtecan significantly improves progression-free survival in patients with HER2-mutant non-small cell lung cancer, with a median PFS of 14.3 months compared to 8.3 months with pembrolizumab plus chemotherapy. T-DXd also demonstrated a higher objective response rate and better d...

In the PAPILLON study, first-line amivantamab-chemotherapy demonstrates the longest overall survival reported for EGFR exon 20 insertion-positive advanced NSCLC

The PAPILLON study demonstrates the longest overall survival for patients with EGFR exon 20 insertion-positive advanced NSCLC using first-line amivantamab-chemotherapy. The study found a median overall survival of 34.3 months with amivantamab-chemotherapy versus 27.9 months with chemotherapy.

The Lancet: New US Medicare pricing policies could reshape global pharmaceutical markets, potentially driving up prices and delaying medicine launches worldwide, study suggests

A new US Medicare pricing policy could reshape global pharmaceutical markets, potentially driving up prices and delaying medicine launches worldwide. The study estimates that Medicare could save $5.2 billion under its initial phase, with savings rising to $21 billion if expanded to all Medicare beneficiaries.

SourceThe Lancet·JournalThe Lancet·TypeComputational simulation/modeling·DateSep 13, 2026

Smartphones could be used to screen for cataracts and other eye problems

Researchers developed a low-cost smartphone attachment to capture diagnostic-quality eye images, which can be reviewed remotely by ophthalmologists. Community health workers and remote ophthalmologists agreed on 96% of cataract diagnoses, challenging the assumption that specialist presence is necessary for accurate screening.